Literature DB >> 6573942

Hepatic failure secondary to indicine N-oxide toxicity. A Pediatric Oncology Group Study.

B A Cook, J R Sinnhuber, P J Thomas, T A Olson, T A Silverman, R Jones, V M Whitehead, F B Ruymann.   

Abstract

Indicine N-oxide, a pyrrolizidine alkaloid, was given to a five-year-old boy with refractory acute myelocytic leukemia. Three days after receiving the drug the patient developed signs and symptoms of acute hepatic failure. The patient died nine days after receiving the drug and an autopsy showed massive hepatic necrosis. The acute hepatic failure observed in this patient may have been secondary to indicine N-oxide toxicity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6573942     DOI: 10.1002/1097-0142(19830701)52:1<61::aid-cncr2820520112>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

Review 1.  New drug development for pediatric oncology.

Authors:  S Weitman; L Carlson; C B Pratt
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

2.  Phase I trial of indicine-N-oxide in children with leukemia and solid tumors: a Pediatric Oncology Group study.

Authors:  V M Whitehead; M L Bernstein; R Vega; T Vats; P Dyment; T J Vietti; J Krischer
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 3.  Heliotropium indicum L.: From Farm to a Source of Bioactive Compounds with Therapeutic Activity.

Authors:  Chandan Sarkar; Milon Mondal; Bilkis Khanom; Md Monir Hossain; Md Solayman Hossain; Antoni Sureda; Muhammad Torequl Islam; Miquel Martorell; Manoj Kumar; Javad Sharifi-Rad; Ahmed Al-Harrasi; Ahmed Al-Rawahi
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-01       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.